Finding hard-to-detect breast cancer

Breast-specific gamma imaging (BSGI) is effective in the detection of cancers not found on mammograms or by clinical exam, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

Image taken using breast-specific gamma imaging (BSGI).
Image taken using breast-specific gamma imaging (BSGI).

"BSGI can identify the most difficult to detect breast cancer—invasive lobular carcinoma," said lead author Rachel F. Brem, M.D., professor of radiology and director of the Breast Imaging and Interventional Center at The George Washington University Medical Center in Washington, D.C. "It also can help us detect additional lesions of all types of breast cancer in women whose mammograms show only one suspicious lesion."
 

Breast cancer affects more women than any other non-skin cancer and, according to the American Cancer Society, accounts for more than 40,000 deaths annually in the U.S. Most experts agree that the best way to decrease breast cancer mortality is through early detection using mammography and clinical breast exam. However, some cancers are difficult to detect with mammography and clinical exam, particularly in the earliest stage when treatment is most effective.
 

While mammography findings are characterized by the difference in appearance between normal and suspicious breast tissue, BSGI findings are based on how cancerous cells function. "It is this physiological approach to breast cancer diagnosis that allows for improved cancer detection," Dr. Brem said.
 

BSGI is an emerging molecular imaging technology using a high-resolution gamma camera that allows for imaging with very mild compression of the breast along with an injection of a low-dose nuclear material called a radiotracer, which is absorbed by the cells. Because cancerous cells have a higher rate of metabolic activity, the tracer is taken up by these cells at a higher level than in normal cells.
 

Dr. Brem and colleagues reviewed the records of 159 women with at least one suspicious or cancerous lesion found by mammography or physical exam, who had undergone BSGI to determine if additional lesions were present.
BSGI results showed an additional suspicious lesion missed by mammography and physical exam in 46 (29 percent) of the women. In 14 (36 percent) of the 39 women who underwent biopsy, the newly discovered lesions were cancerous.
"The data suggest that BSGI allows for the diagnosis of more and earlier breast cancers," Dr. Brem said.
 

Dr. Brem pointed out that BSGI is not meant to replace mammography, but to be used as an adjunct to mammography. "It is an excellent tool for locating difficult-to-detect cancers and for screening high-risk women who have normal mammograms and physical examination," she said.
 

04.12.2008

More on the subject:

Related articles

Photo

News • Sex differences of coronary microvascular dysfunction

Study reveals hidden heart risks in women with type 2 diabetes

Women with type 2 diabetes are nearly twice as likely as men to have hidden heart damage, according to a major new study. This could lead to sex-specific risk assessment and treatments.

Photo

News • Research on PMS, PMDD and CVD

Premenstrual symptoms put women at risk of cardiovascular disease

Women suffering from premenstrual syndrome (PMS) or the more severe form, premenstrual dysphoric disorder (PMDD), have a higher risk of developing cardiovascular disease, a new study shows.

Photo

Article • Respiratory health

Pulmonary embolism in pregnancy: diagnostic pathways under scrutiny

Pulmonary embolism (PE) remains one of the leading causes of maternal mortality. At the French Thoracic Society Spring Days in May, Dr Aurélie Dehaene, radiologist at European Hospital in Marseille,…

Related products

Subscribe to Newsletter